Eli Lilly antibody treatment stopped due to spread of COVID-19 variants

The U.S. government has stopped the use of Eli Lilly’s COVID-19 monoclonal antibody treatments due to the spread of COVID-19 variants. The announcement about bamlanivimab came Wednesday from the Department of Health and Human Services’…